The obesity epidemic is a global issue and shows no signs of abating, while the cause of
this epidemic remains unclear. Marketing practices of energy-dense foods and institutionally …

Antipsychotic-induced weight gain is an important issue in the treatment of psychotic
illnesses, and affects 80% of individuals being treated with antipsychotic drugs. However …

Introduction Antipsychotics (AP) induce weight gain. However, reviews and meta-analyses
generally are restricted to second generation antipsychotics (SGA) and do not stratify for …

Context Cardiometabolic effects of second-generation antipsychotic medications are
concerning but have not been sufficiently studied in pediatric and adolescent patients naive …

Importance The fact that individuals with schizophrenia have high cardiovascular morbidity
and mortality is well established. However, risk status and moderators or mediators in the …

Cardiovascular toxicity remains a major cause of concern during preclinical and clinical
development as well as contributing to post-approval withdrawal of medicines. This issue is …

Metabolic syndrome with the atypical antipsychotics : Current Opinion in Endocrinology,
Diabetes and Obesity Metabolic syndrome with the atypical antipsychotics : Current Opinion in …

Prescriptions for second-generation antipsychotics (SGAs) have surpassed those for first-
generation agents in the treatment of schizophrenia and bipolar disorder. While SGAs have …

BackgroundThere is an ongoing debate about the use of atypical antipsychotics as a first-
line treatment for first-episode psychosis. AimsTo examine the evidence base for this …

Beside the therapeutic improvement over first-generation antipsychotics, the fact that
prescription of atypical agents is also associated to the emergence of severe metabolic …